Cargando…

Antidyslipidemic drugs in metabolic syndrome

Detalles Bibliográficos
Autor principal: Patil, Anant D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872704/
https://www.ncbi.nlm.nih.gov/pubmed/24381903
http://dx.doi.org/10.4103/2230-8210.122652
_version_ 1782297010801475584
author Patil, Anant D.
author_facet Patil, Anant D.
author_sort Patil, Anant D.
collection PubMed
description
format Online
Article
Text
id pubmed-3872704
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38727042013-12-31 Antidyslipidemic drugs in metabolic syndrome Patil, Anant D. Indian J Endocrinol Metab Letters to the Editor Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3872704/ /pubmed/24381903 http://dx.doi.org/10.4103/2230-8210.122652 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Patil, Anant D.
Antidyslipidemic drugs in metabolic syndrome
title Antidyslipidemic drugs in metabolic syndrome
title_full Antidyslipidemic drugs in metabolic syndrome
title_fullStr Antidyslipidemic drugs in metabolic syndrome
title_full_unstemmed Antidyslipidemic drugs in metabolic syndrome
title_short Antidyslipidemic drugs in metabolic syndrome
title_sort antidyslipidemic drugs in metabolic syndrome
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872704/
https://www.ncbi.nlm.nih.gov/pubmed/24381903
http://dx.doi.org/10.4103/2230-8210.122652
work_keys_str_mv AT patilanantd antidyslipidemicdrugsinmetabolicsyndrome